Katja Adie1, Christine Schofield2, Margie Berrow3, Jennifer Wingham2,4, John Humfryes5, Colin Pritchard2, Martin James6, Rhoda Allison7. 1. 1 Stroke and Eldercare, Royal Cornwall Hospital Trust, Cornwall, UK. 2. 2 Research, Development and Innovation, Royal Cornwall Hospital Trust, Truro, UK. 3. 3 Peninsula Clinical Trials Unit, Plymouth University Schools of Medicine and Dentistry, Plymouth, UK. 4. 4 University of Exeter Medical School (Primary Care), St Luke's Campus, Exeter, UK. 5. 5 Patient representative. 6. 6 Royal Devon & Exeter Hospital/University of Exeter Medical School, Exeter, UK. 7. 7 Torbay and South Devon NHS Foundation Trust, Newton Abbott Hospital, Devon, UK.
Abstract
OBJECTIVE: The Trial of Wii™ in Stroke investigated the efficacy of using the Nintendo Wii Sports™ (WiiTM) to improve affected arm function after stroke. DESIGN: Multicentre, pragmatic, parallel group, randomized controlled trial. SETTING: Home-based rehabilitation. SUBJECTS: A total of 240 participants aged 24-90 years with arm weakness following a stroke within the previous six months. INTERVENTION: Participants were randomly assigned to exercise daily for six weeks using the WiiTM or arm exercises at home. MAIN MEASURES: Primary outcome was change in the affected arm function at six weeks follow-up using the Action Research Arm Test. Secondary outcomes included occupational performance, quality of life, arm function at six months and a cost effectiveness analysis. RESULTS: The study was completed by 209 participants (87.1%). There was no significant difference in the primary outcome of affected arm function at six weeks follow-up (mean difference -1.7, 95% CI -3.9 to 0.5, p = 0.12) and no significant difference in secondary outcomes, including occupational performance, quality of life or arm function at six months, between the two groups. No serious adverse events related to the study treatment were reported. The cost effectiveness analysis showed that the WiiTM was more expensive than arm exercises £1106 (SD 1656) vs. £730 (SD 829) (probability 0.866). CONCLUSION: The trial showed that the WiiTM was not superior to arm exercises in home-based rehabilitation for stroke survivors with arm weakness. The WiiTM was well tolerated but more expensive than arm exercises.
RCT Entities:
OBJECTIVE: The Trial of Wii™ in Stroke investigated the efficacy of using the Nintendo Wii Sports™ (WiiTM) to improve affected arm function after stroke. DESIGN: Multicentre, pragmatic, parallel group, randomized controlled trial. SETTING: Home-based rehabilitation. SUBJECTS: A total of 240 participants aged 24-90 years with arm weakness following a stroke within the previous six months. INTERVENTION: Participants were randomly assigned to exercise daily for six weeks using the WiiTM or arm exercises at home. MAIN MEASURES: Primary outcome was change in the affected arm function at six weeks follow-up using the Action Research Arm Test. Secondary outcomes included occupational performance, quality of life, arm function at six months and a cost effectiveness analysis. RESULTS: The study was completed by 209 participants (87.1%). There was no significant difference in the primary outcome of affected arm function at six weeks follow-up (mean difference -1.7, 95% CI -3.9 to 0.5, p = 0.12) and no significant difference in secondary outcomes, including occupational performance, quality of life or arm function at six months, between the two groups. No serious adverse events related to the study treatment were reported. The cost effectiveness analysis showed that the WiiTM was more expensive than arm exercises £1106 (SD 1656) vs. £730 (SD 829) (probability 0.866). CONCLUSION: The trial showed that the WiiTM was not superior to arm exercises in home-based rehabilitation for stroke survivors with arm weakness. The WiiTM was well tolerated but more expensive than arm exercises.
Authors: Yu Chen; Kingsley Travis Abel; John T Janecek; Yunan Chen; Kai Zheng; Steven C Cramer Journal: Int J Med Inform Date: 2018-12-11 Impact factor: 4.046
Authors: Marysol Cacciata; Anna Stromberg; Jung-Ah Lee; Dara Sorkin; Dawn Lombardo; Steve Clancy; Adeline Nyamathi; Lorraine S Evangelista Journal: Int J Nurs Stud Date: 2019-02-10 Impact factor: 5.837
Authors: Helen Rodgers; Helen Bosomworth; Hermano I Krebs; Frederike van Wijck; Denise Howel; Nina Wilson; Tracy Finch; Natasha Alvarado; Laura Ternent; Cristina Fernandez-Garcia; Lydia Aird; Sreeman Andole; David L Cohen; Jesse Dawson; Gary A Ford; Richard Francis; Steven Hogg; Niall Hughes; Christopher I Price; Duncan L Turner; Luke Vale; Scott Wilkes; Lisa Shaw Journal: Health Technol Assess Date: 2020-10 Impact factor: 4.014
Authors: Bernadette C Tobler-Ammann; Elif Surer; Eling D de Bruin; Marco Rabuffetti; N Alberto Borghese; Renato Mainetti; Michele Pirovano; Lia Wittwer; Ruud H Knols Journal: JMIR Serious Games Date: 2017-08-25 Impact factor: 4.143
Authors: Steinunn A Olafsdottir; Helga Jonsdottir; Charlotte Magnusson; Héctor Caltenco; Mikko Kytö; Laura Maye; David McGookin; Ingibjörg Bjartmarz; Solveig Asa Arnadottir; Ingibjörg Hjaltadottir; Thora B Hafsteinsdottir Journal: BMC Health Serv Res Date: 2020-05-25 Impact factor: 2.655